ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,291.34
0.15%
US Tech 100
18,220.00
0.25%
다우존스 지수
38,711.29
0.36%
Bitcoin
71,051.16
0.60%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Therapix Biosciences Ltd (TRPX)

  7. Therapix Biosciences Ltd (TRPX) 뉴스

TRPX

Therapix Biosciences (TRPX)

Therapix Biosciences Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TRPX
일자시간출처헤드라인심볼기업
2023/06/2705:05Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/06/2122:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/06/1622:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/06/1220:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/05/3105:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/05/1719:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/05/1706:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TRPXTherapix Biosciences Ltd
2023/05/0821:24Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/05/0605:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/04/2122:13Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/04/0519:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/04/0420:08Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/03/1107:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/03/1006:16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRPXTherapix Biosciences Ltd
2023/02/2723:14Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/02/2721:47Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/02/1720:01Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:TRPXTherapix Biosciences Ltd
2023/02/1707:25Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/02/1522:35Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/01/2606:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2023/01/1006:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/12/1506:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/12/0803:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/11/3002:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/11/1706:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/11/0821:34Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/11/0205:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/09/3020:28Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/09/1700:04Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
2022/08/2519:56Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:TRPXTherapix Biosciences Ltd
 검색 관련기사 보기:NASDAQ:TRPX

최근 히스토리

NASDAQI
RXRESCNR
Benchmark Healthcare Rea...
BOV
VALEL755
VALEL755 Ex:72,83
ASX
BP8O
BPH Global
EU
ALFLO
Florentaise
COIN
IPTGBP
COIN
TAIZOUSD
Taizo Hori
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유